InnoScience (Suzhou) Technology Holding Co., Ltd. (Stock Code: 2577) disclosed announced revisions to the annual caps under its existing Framework Agreement for Sale of Products, Services and Equipment with Stark Semiconductor. Due to an expected rapid increase in cooperation business volume, the original annual caps for the two financial years ending December 31, 2026 and December 31, 2027 were deemed insufficient, leading to the signing of a Supplemental Agreement on February 2, 2026.

Under the revised arrangement, the 2026 caps for GaN EPI wafers, outbound testing services, and epitaxial growth equipment are RMB22,000,000, RMB1,300,000, and RMB18,000,000 respectively. For 2027, they are RMB3,000,000, RMB1,500,000, and RMB5,400,000 respectively. These figures were determined based on Stark Semiconductor’s higher anticipated demand for GaN-on-Si wafers, testing services, and equipment, as it accelerates Micro-LED commercialization and related AI application development.

Stark Semiconductor is ultimately controlled by Dr. Luo, who is among InnoScience (Suzhou) Technology Holding Co., Ltd.’s controlling shareholders. As a result, these transactions remain subject to the reporting, announcement, and annual review requirements under Chapter 14A of the Listing Rules, though they are exempt from independent shareholders’ approval. According to the announcement, these revisions are intended to align with projected demand, facilitate ongoing collaboration, and allow InnoScience (Suzhou) Technology Holding Co., Ltd. to optimize its production line by selling mature equipment as it upgrades to more advanced technologies.